<DOC>
	<DOC>NCT00919776</DOC>
	<brief_summary>Study 2B: Ciclosporin in the management of chronic or recurrent Erythema Nodosum Leprosum Aim: To assess the safety, tolerability and efficacy of Ciclosporin in the treatment of patients whose ENL is not controlled with standard Prednisolone. Objective: A pilot double blind controlled study randomizing patients whose ENL is not controlled with standard Prednisolone, and comparing a group treated with Ciclosporin to a group treated with additional steroid only.</brief_summary>
	<brief_title>Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum</brief_title>
	<detailed_description>A pilot double blind controlled study randomizing patients whose ENL is not controlled with standard Prednisolone, and comparing a group treated with Ciclosporin to a group treated with additional steroid only.</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<mesh_term>Erythema Nodosum</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Individuals with clinical evidence of recurrent or chronic ENL Aged 1865 Weigh more than 30Kg Unwillingness to give informed consent Patients with severe active infections such as tuberculosis Pregnant or breastfeeding women (see Appendix II) Those with renal failure, abnormal renal function, hypertensive Patients taking thalidomide currently or within the last 3 months Patients not willing to return for followup Women of reproductive age not willing to use contraception for the duration of the study ( see Appendix II) HIV positive patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Leprosy</keyword>
	<keyword>ENL</keyword>
	<keyword>Erythema Nodosum Leprosum</keyword>
	<keyword>Prednisolone</keyword>
	<keyword>Ciclosporin</keyword>
</DOC>